Articles in Science, Axios and the most recent in The Scientist https://lnkd.in/g5m_6mvk draw attention to the critical importance of #biosecurity, a topic that Ansa takes seriously. We are an active member of the International Gene Synthesis Consortium and we adhere to the IGSC’s Harmonized Screening Protocol. Before being synthesized, all sequences requested from Ansa are screened according to the US Department of Health and Human Services’ Screening Framework Guidance.
Ansa Biotechnologies, Inc.
Biotechnology Research
Emeryville, California 7,113 followers
High-fidelity DNA synthesis using enzymes
About us
At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability. Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page.
- Website
-
http://www.ansabio.com
External link for Ansa Biotechnologies, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Emeryville, California
- Type
- Privately Held
- Founded
- 2018
- Specialties
- DNA
Locations
-
Primary
1198 65th St
Suite 250
Emeryville, California 94608, US
Employees at Ansa Biotechnologies, Inc.
-
Scott Kosch
Advisor and Investor
-
Jason T. Gammack
Chief Executive Officer at Ansa Biotechnologies
-
Bethany Dalton Hoover
Global E2E Business Operations Leadership | Strategic Process Improvement | Commercial & Supply Chain Operations | Cross-Functional Project…
-
Evan King
Life Sciences Commercial | Strategic Accounts; Pharma, Clinical Trials, CRO
Updates
-
💭 A dream delayed is not a dream denied. Let us help you make your #DNAsynthesis dreams a reality. Ansa has reengineered the DNA manufacturing process, so that you can get the most challenging sequences delivered on time, reliably and efficiently. Find out more: https://lnkd.in/gA6hZXdf #SyntheticDNA #synbio
-
-
In our latest blog post https://lnkd.in/gMbGwdTz, read how Touchlight, a CDMO in London, has partnered with Ansa to obtain the complex sequences they need to successfully serve their customers working on personalized cancer vaccines.
Enabling New Access to Complex DNA for Vaccine Development
https://ansabio.com
-
If you missed our webinar, you can view it on-demand https://lnkd.in/g9FJCFA4 to learn how products with repetitive sequences from Ansa have enabled discovery and harnessing of the next generation of gene editors by multiplexing gene editors and testing novel plasmid systems. #syntheticdna #enzymaticdna #GeneEditing
-
-
Hear from New England Biolabs molecular biologist, Greg Lohman, in this brief video, as he talks about how working with Ansa has enabled his team to build fully synthetic systems that were not possible before. #complexDNA #biology #syntheticDNA
-
Join us https://lnkd.in/g9FJCFA4 on Aug 6 and hear from one of our customers at the Innovative Genomics Institute to learn about their work developing delivery methods for microbial #genome editors, such as #bacteriophage and #plasmids, and how working with Ansa has enabled their access to #complexDNA.
-
-
Join us https://lnkd.in/g9FJCFA4 during our live webinar, "Complex DNA Synthesis for Your Most Ambitious Projects," to explore the possibilities of having access to a novel technology that is able to deliver complex #DNA sequences rapidly and reliably. #lifescience #microbiome #celltherapy #genetherapy #biotech #syntheticDNA
Webinar: Complex DNA for Your Most Ambitious ProjectsWebinar:
https://ansabio.com
-
In this blog post https://lnkd.in/g3Zkzpcq, read about the complex sequences Ansa is delivering on, enabled by our #enzymaticDNA synthesis technique that is superior to the prior gold standard, the phosphoramidite method. #DNA #biotech #lifesciences
Accelerating Life Sciences
https://ansabio.com
-
Our co-founder and CSO Daniel Lin-Arlow shares his thoughts about an important milestone: the commercial launch of our very first #syntheticDNA products. #DNA
Celebrating the official launch of our DNA synthesis service, plus a preview of great things to come! #DNA #DNAsynthesis #genesynthesis
It’s a new day for complex DNA
Daniel Lin-Arlow on LinkedIn
-
We’re thrilled to announce the launch of our first commercial products, Ansa Clonal DNA and Ansa DNA Fragments. With ultra-rapid, assembly-free production of #complexDNA sequences up to 600 bp, we aim to help customers achieve their most ambitious projects. Ansa is now the only company able to synthesize contiguous #DNA sequences as long as 600 bp at scale in sequence-perfect clonal DNA or sequence-verified linear double-stranded DNA fragment formats. Our early access partners have been able to push the limits of their research: “As we develop technologies to achieve precision microbiome genetic engineering, we routinely rely on complex DNA sequences, such as highly repetitive microbial replicons and guide RNA arrays. Ansa was the only company that could deliver these complex sequences, allowing us to test microbial editing tools previously inaccessible to us.” — Postdoctoral scientist Jaymin Patel, PhD, UC Berkeley #DNAsynthesis #biotech #enzymaticDNA https://lnkd.in/gPJgEFzp
Ansa Biotechnologies Pushes Limits of Complex DNA Synthesis with Launch of New Commercial Products
businesswire.com